Claim · 2025-02 · announcement · Stated in source · Supported

Isomorphic Labs' partnerships page (as served on 2026-10-30) states that Isomorphic and Novartis announced an expansion of their partnership in February 2025, adding up to three research programmes to the initial three targets.

One recorded claim. The claim panel gives its qualification, the source passages with their place in each source, and how it was checked.

What it connects

Isomorphic Labs → announced a partnership with → Novartis

Where it appears

No collection page holds this claim. It is listed with its records in the explorer.

Claim and evidence

Isomorphic Labsannounced a partnership with ↓Novartis

Machine-checked, not reviewed by an editorStated in sourceSupported

Supporting evidence: primary · 1 source

Date: 2025-02 · announcement Records dated 2025 →
Activity stage: announced

Scope and limitsRests on the company's later page, not on the February 2025 announcement; no terms of the expansion are stated there. "Up to three" programmes is the stated bound.

The evidence 01

primary sourceSupports the claim

Partnerships

Isomorphic Labs · Publication date unknown

Cite the original source

Cite the original document, not Selekoa. Check these details against it.

Source excerpt

“Iso and Novartis announced an expansion of our partnership in February 2025. The initial scope of our research collaboration was focused on the discovery of small molecule therapeutics against three particularly challenging targets. That has now been expanded - adding up to three additional research programs.”

Location in source Novartis panel, "details of our collaboration"

How it was read Retrieved directly from the publisher

Machine-checked · 2026-10-30

Source details and check notes

Authors: Isomorphic Labs
Version: Retrieved for the candidate pack on 2026-10-30 (SHA-256 f94ef5d335e1421267bb3343002832c8fd67e7544490368762b11bc1385332aa). Partnerships page as served on 2026-10-30 (undated: snapshot). Its wording can change; earlier wording is not authenticated.
Canonical address: Open the canonical source ↗
Accessed: 2026-10-30
Language: English (en)
Attribution: Isomorphic Labs, “Partnerships”.
Reuse: No open redistribution licence asserted. Bibliographic metadata, editorial paraphrases and short attributed quotations (at most 50 words each). Recheck terms before wider redistribution.
Check notes: Candidate pack passage, AI in biology (research/ai-in-biology). The quotation (45 words) matched the text retrieved for the candidate pack on 2026-10-30. Matching ignored differences of whitespace, case, quotation marks, dashes and Unicode compatibility forms, so the source’s typography can differ. A cross-family machine check (2026-10-30, item A24) answered the record’s question blind from fresh retrievals and agreed with the record. No human editorial review.

Status and meaning

Editorial status. Not reviewed by an editor. An exploratory record that no editor has accepted. This status does not say whether a person has read any linked passage. Each evidence record above shows how it was checked.

Relation. An organisation announced a collaboration or partnership with a named counterparty, as the announcement states it (stage announced). It is not evidence that the work was performed, that a payment was made or that the arrangement continues; an “up to” amount stays in the statement.

Date. Month as stated by the later page; the February 2025 announcement itself was not retrieved.

Record ID aib-labs-iso-novartis-expansion-2025